| 臺大學術典藏 |
2020-12-18T08:38:17Z |
Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10
|
Liao C.-H.; Huang Y.-T.; Tan C.-K.; Lai C.-C.; Lai C.-C.;Tan C.-K.;Huang Y.-T.;Liao C.-H.;Po-Ren Hsueh; PO-REN HSUEH |
| 臺大學術典藏 |
2021-05-18T05:56:51Z |
Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10
|
Lai C.-C.; Tan C.-K.; YU-TSUNG HUANG; Liao C.-H.; Hsueh P.-R. |
| 國立成功大學 |
2021 |
Fluoroquinolones and Aortic Disease - Reply
|
Dong, Y.-H.;Wang, J.-L.;Lin, J.-W. |
| 國立臺灣大學 |
2015 |
Fluoroquinolones versus beta-Lactam/beta-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study
|
Lin, Kuan-Yin; Wang, Chi-Chuan; Lin, Chia-Hui; Sheng, Wang-Huei; Chang, Shan-Chwen; 張上淳; 王繼娟; 盛望徽 |
| 臺大學術典藏 |
2019 |
Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis
|
Peck K.R.; Chung D.R.; Kim Y.-J.; Shiratori S.; Cho S.-Y.; Lee D.-G.; Matsumura Y.; Sekiya N.; Kim S.-H.; PO-REN HSUEH; G?zel M.G.; Cho S.Y.; Wang C.-H.; Yeh K.-M.; Cornejo-Ju?rez P.; Kang C.-I.; Ko J.-H.; Peck K.R.;Chung D.R.;Kim Y.-J.;Shiratori S.;Cho S.-Y.;Lee D.-G.;Matsumura Y.;Sekiya N.;PO-REN HSUEH;Kim S.-H.;G?zel M.G.;Cho S.Y.;Wang C.-H.;Yeh K.-M.;Cornejo-Ju?rez P.;Kang C.-I.;Ko J.-H. |
| 臺大學術典藏 |
2020-12-18T08:37:00Z |
Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis
|
Ko J.-H.;Kang C.-I.;Cornejo-Ju?Rez P.;Yeh K.-M.;Wang C.-H.;Cho S.Y.;G?Zel M.G.;Kim S.-H.;Po-Ren Hsueh;Sekiya N.;Matsumura Y.;Lee D.-G.;Cho S.-Y.;Shiratori S.;Kim Y.-J.;Chung D.R.;Peck K.R.; Ko J.-H.; Kang C.-I.; Cornejo-Ju?rez P.; Yeh K.-M.; Wang C.-H.; Cho S.Y.; G?zel M.G.; Kim S.-H.; PO-REN HSUEH; Sekiya N.; Matsumura Y.; Lee D.-G.; Cho S.-Y.; Shiratori S.; Kim Y.-J.; Chung D.R.; Peck K.R. |
| 臺大學術典藏 |
2018-09-10T15:18:05Z |
Fluoroquinolones versus β-lactam/β- lactamase inhibitors in outpatients with chronic obstructive pulmonary disease and pneumonia: A nationwide population-based study
|
Lin, K.-Y. and Wang, C.-C. and Lin, C.-H. and Sheng, W.-H. and Chang, S.-C.; Lin, Kuan-Yin;Wang, Chi-Chuan;Lin, Chia-Hui;Sheng, Wang-Huei;Chang, Shan-Chwen; 張上淳;王繼娟;盛望徽; 莊立民; 田郁文; 張以承; 孫家棟; Chang, Emily Yun-Chia; Lin, Kuan-Yin; WANG-HUEI SHENG; CHI-CHUAN WANG; Wang, Chi-Chuan; Chang, Yi-Cheng; SHAN-CHWEN CHANG; Lin, Chia-Hui; Shun, Chia-Tung; Sheng, Wang-Huei; Tien, Yu-Wen; Tsai, Shu-Huei; Chang, Shan-Chwen; Hee, Siow-Wey; Chen, Ing-Jung; Chuang, Lee-Ming |
| 臺大學術典藏 |
2021-08-27T06:48:56Z |
Fluoroquinolones versus β-lactam/β- lactamase inhibitors in outpatients with chronic obstructive pulmonary disease and pneumonia: A nationwide population-based study
|
KUAN-YIN LIN; Wang C.-C.; Lin C.-H.; Sheng W.-H.; Chang S.-C. |
| 臺大學術典藏 |
2021-02-26T01:59:39Z |
Fluoroquinolones versus β-lactam/β- lactamase inhibitors in outpatients with chronic obstructive pulmonary disease and pneumonia: A nationwide population-based study
|
Lin K.-Y.;Wang C.-C.;Lin C.-H.;Wang-Huei Sheng;Chang S.-C.; Lin K.-Y.; Wang C.-C.; Lin C.-H.; WANG-HUEI SHENG; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:16Z |
Fluoroquinolones versus β-lactam/β- lactamase inhibitors in outpatients with chronic obstructive pulmonary disease and pneumonia: A nationwide population-based study
|
KUAN-YIN LIN; Wang C.-C.; Lin C.-H.; Sheng W.-H.; Chang S.-C. |
